Genseq

Executive Summary

Genseq is a Dublin-based private company providing ISO 15189 accredited clinical genetic testing services to healthcare professionals and genomic solutions to biopharma and clinical research organizations worldwide. Founded in 2015, the company operates in the genetics and diagnostics sectors, leveraging its accreditation to ensure high-quality testing. With the growing demand for precision medicine and companion diagnostics, Genseq is well-positioned to expand its offerings. However, as a private entity with limited public financial or pipeline data, its near-term trajectory is uncertain but promising given the tailwinds in genomics.

Upcoming Catalysts (preview)

• Q3 2026Announcement of a major biopharma partnership for companion diagnostic development50% success
• Q4 2026Receipt of FDA or CE-IVDR approval for a new clinical genetic test40% success
• Q2 2026Completion of a Series A or B funding round to accelerate commercialization60% success